Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial

BACKGROUND: Digoxin is widely used in patients with atrial fibrillation despite the lack of randomized controlled trials. Observational studies report conflicting results regarding its association with mortality, perhaps because of residual confounding by the presence of heart failure (HF). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisen, Alon, Ruff, Christian T., Braunwald, Eugene, Hamershock, Rose A., Lewis, Basil S., Hassager, Christian, Chao, Tze‐Fan, Le Heuzey, Jean Yves, Mercuri, Michele, Rutman, Howard, Antman, Elliott M., Giugliano, Robert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586309/
https://www.ncbi.nlm.nih.gov/pubmed/28666993
http://dx.doi.org/10.1161/JAHA.117.006035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586309/
https://www.ncbi.nlm.nih.gov/pubmed/28666993
http://dx.doi.org/10.1161/JAHA.117.006035

Ejemplares similares